Tech Company Financing Transactions
Cofactor Genomics Funding Round
On 9/19/2017, Cofactor Genomics secured $18 million in Series A funding from Menlo Ventures, Ascension Ventures and Data Collective.
Transaction Overview
Company Name
Announced On
9/19/2017
Transaction Type
Venture Equity
Amount
$18,000,000
Round
Series A
Investors
Menlo Ventures (Lead Investor) (Mark Siegel)
Ascension Ventures (John Kuelper)
Data Collective (Matthew Ocko)
Proceeds Purpose
We at Menlo are happy to be supporting the growth of Cofactor and their team with decades of genomics experience as they leverage their powerful technology to write this new chapter.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
300 Brannan St.
San Francisco, CA 94107
USA
San Francisco, CA 94107
USA
Phone
Website
Email Address
Overview
Cofactor Genomics is an RNA products, RNA diagnostics, and RNA-seq service provider. We are the leaders in RNA Sequencing.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jarret Glasscock
Chief Medical Officer
Eric Duncavage
Chief Operating Officer
David Messina
Chief Scientific Officer
Jon Armstrong
Browse more venture capital transactions:
Prev: 9/19/2017: Kaleido Biosciences venture capital transaction
Next: 9/19/2017: LifeMine Therapeutics venture capital transaction
Share this article
About Our VC Transactions Data
We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs